Polomar Health Services Scraps Altanine Merger, Ends Key IP License
PMHS sits 44% above its 52-week low of $0.065 on light trading volume (0.4× avg).
Summary
Polomar Health Services has mutually terminated its merger agreement with Altanine, Inc., effective June 12, 2026. Concurrently, the company ended its Know How and Patent License Agreement with Pinata Holdings, with a sell-off period for remaining inventory until September 7, 2026. This follows an 8-K filed earlier today and adds to a string of negative developments, including a prior distribution agreement termination, a going concern warning, and a major lawsuit with a $20 million claim. The termination of this strategic merger and related IP license removes a critical path forward for the micro-cap company, which is already facing significant financial distress.
At the time of this announcement, PMHS was trading at $0.09 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $0.07 to $960,000.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.